Results 221 to 230 of about 77,045 (328)

Early Hemostatic Treatment Could Improve 30‐Day Survival After Spontaneous Rupture of Hepatocellular Carcinoma

Liver International, Volume 45, Issue 10, October 2025.
ABSTRACT Introduction Spontaneous rupture of hepatocellular carcinoma (SRHCC) presents a critical clinical challenge, with early haemostasis often difficult to achieve and limited data available on subsequent treatment strategies. This study aims to evaluate whether the initial hemostatic approach influences early prognosis and facilitates further ...
Apolline Commin, Chloé Metivier, Manon Allaire, Jean Lubrano, Amandine Claudinot, Audrey Coilly, Marc‐Antoine Allard, Charles Roux, Olivier Scatton, Jean Charles Nault, Olivier Sutter, Nathalie Ganne‐Carrié, Thuy Vi Ngo, Valérie Le Goff, Zeineb Ben Ali, Husni Tedlaouti, Josephine Papin, Marion Habireche, Louise Lebedel, Claire Pérignon, Thông Dao, Rémy Morello, Isabelle Ollivier‐Hourmand   +22 more
wiley   +1 more source

Noninvasive prediction of high-risk esophageal varices by spleen and liver stiffness measurements using sound touch elastography. [PDF]

Liver Res
Wang J, Tan S, Zheng R, Ke B, Wu B, Wu M.   +5 more
europepmc   +1 more source

Hemodynamics of gastric varices. Study by percutaneous transhepatic portography.

, 1987
Kiyoshi Watanabe, Kunio Kimura, Shoichi Matsutani, Masao Ohto, Kunio Okuda   +4 more
openalex   +2 more sources

Real‐World Outcomes of Atezolizumab–Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort

Liver International, Volume 45, Issue 10, October 2025.
ABSTRACT Background and Aims Atezolizumab–Bevacizumab (AtezoBev) was the first immunotherapy approved for hepatocellular carcinoma (HCC) in France, with initial trials primarily involving patients with viral‐related liver disease. This prospective study aimed to evaluate the efficacy of AtezoBev in a French HCC population predominantly affected by non ...
Manon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, Mohamed Bouattour, Julien Edeline, Bleuenn Brusset, Marianne Ziol, Philippe Merle, Jean Frédéric Blanc, Thomas Uguen, Nathalie Ganne, Stéphane Cattan, Ghassan Riachi, Véronique Loustaud‐Ratti, Thomas Decaens, Christine Silvain, Jean Marie Peron, Aurore Baron, Georges Philippe Pageaux, Frédéric Oberti, Rodolphe Anty, Alina Pascale, Sylvain Manfredi, Marc Bourliere, Jean Baptiste Nousbaum, Alexandra Heurgue, Isabelle Ollivier‐Hourmand, Marie Lequoy, Jean Pierre Bronowicki, Anne Laure Villing, Gerard Ducournau, Olivier Ganry, Charlotte Costentin, Eric Nguyen‐Khac   +33 more
wiley   +1 more source

Noncardiac Procedural Complication Resulting in Pericarditis. [PDF]

JACC Case Rep
Hagan G, Donisan T, Jouni H, Luis SA.
europepmc   +1 more source

PREDICTION OF THE SEVERITY OF LIVER CIRRHOSIS COMPLICATED WITH ESOPHAGEAL VARICES DETERMINED BY iv-GTT

, 1987
Naoki Hashimoto, Yoshinao KOTOURA, Hiroshi Ashida, Yoshio ISHIKAWA, Joji Utsunomiya   +4 more
openalex   +2 more sources

Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab

Liver International, Volume 45, Issue 10, October 2025.
ABSTRACT Background and Aims Hepatitis C virus (HCV) is a key driver of hepatocellular carcinoma (HCC). However, the impact of HCV eradication on systemic therapy remains unclear. We aimed to assess the safety and efficacy of direct‐acting antivirals (DAA) in patients treated with Atezolizumab plus Bevacizumab (AtezoBev).
Leonardo Stella, Giuseppe Cabibbo, Ciro Celsa, Roberta Ciccia, Alba Sparacino, Fabio Piscaglia, Francesco Tovoli, Andrea Arleo, Bernardo Stefanini, Massimo Iavarone, Roberta D'Ambrosio, Lucia Cerrito, Maria Pallozzi, Francesco Santopaolo, Fabio Marra, Claudia Campani, Chiara Mazzarelli, Raffaella Viganò, Raffaella Tortora, Alessio Aghemo, Stella De Nicola, Tiziana Pressiani, Lorenza Rimassa, Sherrie Bhoori, Salvatore Corallo, Laura Maiocchi, Andrea Martini, Caterina Soldà, Francesco Paolo Russo, Antonio Gasbarrini, Francesca Romana Ponziani   +30 more
wiley   +1 more source

Evaluating thresholds of Mac-2 binding protein glycosylation isomer in association with clinical outcomes in patients with cirrhosis. [PDF]

World J Hepatol
Doan TH, Nguyen KM, Nguyen XV, Pham ATN, Le ND.   +4 more
europepmc   +1 more source

CLINICAL EVALUATION OF SURGICAL TREATMENT FOR ESOPHAGEAL VARICES

, 1986
Y Ogawa, Naofumi Nagasue, H Yukaya, Y Sasaki   +3 more
openalex   +2 more sources

Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure

Liver International, Volume 45, Issue 10, October 2025.
ABSTRACT Background and Aims The impact of portal hypertension (PH) during acute‐on‐chronic liver failure (ACLF) remains unclear. This study investigated the link between underlying PH severity, systemic inflammation (SI), and the course of ACLF. Methods Consecutive patients with ACLF (n = 192) who met the EASL‐CLIF criteria were retrospectively ...
Vlad Taru, Georg Kramer, Benedikt S. Hofer, Nina Dominik, Lorenz Balcar, Mathias Schneeweiss‐Gleixner, Bogdan Procopet, Michael Trauner, Mattias Mandorfer, Philipp Schwabl, Thomas Reiberger, Benedikt Simbrunner   +11 more
wiley   +1 more source